DK1042340T3 - 6-O-alkylerythromycinoxim-B - Google Patents

6-O-alkylerythromycinoxim-B

Info

Publication number: DK1042340T3
Authority: DK; Denmark
Prior art keywords: oxime erythromycin; alkyl; alkylerythromycinoxim; alkyl derivative; erythromycin
Prior art date: 1997-12-01

Application number

DK98958055T

Other languages

English (en)

Inventor

Jih-Hua Liu

Stephen H Montgomery

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-01

Filing date

1998-11-17

Publication date

2004-11-29

1998-11-17 Application filed by Abbott Lab filed Critical Abbott Lab

2004-11-29 Application granted granted Critical

2004-11-29 Publication of DK1042340T3 publication Critical patent/DK1042340T3/da

Links

IDRYSCOQVVUBIJ-UHFFFAOYSA-N Erythromycin-B Natural products CC1C(OC2C(C(CC(C)O2)N(C)C)O)C(C)(O)CC(C)C(=O)C(C)C(O)C(C)C(CC)OC(=O)C(C)C1OC1CC(C)(OC)C(O)C(C)O1 IDRYSCOQVVUBIJ-UHFFFAOYSA-N 0.000 abstract 3
IDRYSCOQVVUBIJ-PPGFLMPOSA-N erythromycin B Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@H]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)C)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 IDRYSCOQVVUBIJ-PPGFLMPOSA-N 0.000 abstract 3
208000035143 Bacterial infection Diseases 0.000 abstract 1
208000022362 bacterial infectious disease Diseases 0.000 abstract 1
239000000543 intermediate Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Saccharide Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK98958055T 1997-12-01 1998-11-17 6-O-alkylerythromycinoxim-B DK1042340T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US08/980,918 US5932710A (en)	1997-12-01	1997-12-01	Process for preparing 6-O-alkyl-9-oxime erythromycin B
PCT/US1998/024547 WO1999028332A1 (en)	1997-12-01	1998-11-17	6-o-alkyl erythromycin b oxime
EP98958055A EP1042340B1 (en)	1997-12-01	1998-11-17	6-o-alkyl erythromycin b oxime

Publications (1)

Publication Number	Publication Date
DK1042340T3 true DK1042340T3 (da)	2004-11-29

Family

ID=25527956

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98958055T DK1042340T3 (da)	1997-12-01	1998-11-17	6-O-alkylerythromycinoxim-B

Country Status (13)

Country	Link
US (2)	US5932710A (da)
EP (1)	EP1042340B1 (da)
JP (1)	JP2001525331A (da)
KR (1)	KR20010032688A (da)
AT (1)	ATE277063T1 (da)
AU (1)	AU1417399A (da)
CA (1)	CA2309963C (da)
DE (1)	DE69826520T2 (da)
DK (1)	DK1042340T3 (da)
ES (1)	ES2229550T3 (da)
IL (1)	IL136088A0 (da)
PT (1)	PT1042340E (da)
WO (1)	WO1999028332A1 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001044262A1 (en)	1999-12-16	2001-06-21	Teva Pharmaceutical Industries Ltd.	Processes for preparing clarithromycin polymorphs and novel polymorph iv
AU2261901A (en)	2000-01-11	2001-07-24	Teva Pharma	Processes for preparing clarithromycin polymorphs
US6544555B2 (en)	2000-02-24	2003-04-08	Advancis Pharmaceutical Corp.	Antibiotic product, use and formulation thereof
US6565882B2 (en)	2000-02-24	2003-05-20	Advancis Pharmaceutical Corp	Antibiotic composition with inhibitor
KR20030047873A (ko) *	2000-02-29	2003-06-18	테바 파마슈티컬 인더스트리즈 리미티드	클라리트로마이신 및 클라리트로마이신 중간체의 제조방법, 실질적으로는 옥심이 제거된 클라리트로마이신 및이를 포함하는 약학적 조성물
US20020068078A1 (en)	2000-10-13	2002-06-06	Rudnic Edward M.	Antifungal product, use and formulation thereof
US6541014B2 (en)	2000-10-13	2003-04-01	Advancis Pharmaceutical Corp.	Antiviral product, use and formulation thereof
US6455680B1 (en)	2000-12-21	2002-09-24	Abbott Laboratories	Methods utilizing aryl thioimines in synthesis of erythromycin derivatives
TWI246515B (en)	2001-05-30	2006-01-01	Abbott Lab	An arylation method for the functionalization of O-allyl erythromycin derivatives
JP2006528185A (ja)	2003-07-21	2006-12-14	アドバンシスファーマスーティカルコーポレイション	抗生物質製剤、その使用法及び作成方法
AU2004258949B2 (en)	2003-07-21	2011-02-10	Shionogi, Inc.	Antibiotic product, use and formulation thereof
AU2004258953B2 (en)	2003-07-21	2011-02-10	Shionogi, Inc.	Antibiotic product, use and formulation thereof
CA2535177A1 (en)	2003-08-11	2005-02-24	Advancis Pharmaceutical Corporation	Robust pellet
US8062672B2 (en)	2003-08-12	2011-11-22	Shionogi Inc.	Antibiotic product, use and formulation thereof
AU2004270170B2 (en) *	2003-08-29	2011-01-27	Shionogi, Inc.	Antibiotic product, use and formulation thereof
CA2538064C (en)	2003-09-15	2013-12-17	Advancis Pharmaceutical Corporation	Antibiotic product, use and formulation thereof
CA2572292A1 (en)	2004-07-02	2006-02-09	Advancis Pharmaceutical Corporation	Tablet for pulsed delivery
US8778924B2 (en)	2006-12-04	2014-07-15	Shionogi Inc.	Modified release amoxicillin products
US8357394B2 (en)	2005-12-08	2013-01-22	Shionogi Inc.	Compositions and methods for improved efficacy of penicillin-type antibiotics
WO2007119717A1 (ja) *	2006-04-13	2007-10-25	Taisho Pharmaceutical Co., Ltd.	アルドヘキソピラノース中間体の製造法
RU2455308C2 (ru) *	2006-05-01	2012-07-10	Тайсо Фармасьютикал Ко., Лтд.	Макролидные производные
US8299052B2 (en)	2006-05-05	2012-10-30	Shionogi Inc.	Pharmaceutical compositions and methods for improved bacterial eradication
JPWO2009019868A1 (ja)	2007-08-06	2010-10-28	大正製薬株式会社	１０ａ、１２位架橋型１０ａ−アザライド化合物
US20090054634A1 (en) *	2007-08-09	2009-02-26	Vinod Kumar Kansal	Process for the preparation of clarithromycin
US8299035B2 (en)	2008-05-15	2012-10-30	Taisho Pharmaceutucal Co., Ltd.	10a-azalide compound having 4-membered ring structure
CN102082088B (zh) *	2009-11-30	2012-04-18	上海华虹Nec电子有限公司	在直接化学机械抛光工艺的产品中共用sl掩模板的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3681326A (en) *	1971-01-11	1972-08-01	Abbott Lab	9-substituted erythromycin a and b oximes
US3855203A (en) *	1973-05-03	1974-12-17	Abbott Lab	4{41 -o-sulfonyl erythromycin-9-o-oxime derivatives
JPS5896097A (ja) *	1981-12-01	1983-06-07	Taisho Pharmaceut Co Ltd	エリスロマイシンｂ誘導体
JPS60214796A (ja) *	1984-04-06	1985-10-28	Taisho Pharmaceut Co Ltd	６−０−メチルエリスロマイシン類の製法
JPS61103890A (ja) *	1984-10-26	1986-05-22	Taisho Pharmaceut Co Ltd	６−０−メチルエリスロマイシンａ誘導体
US4670549A (en) *	1985-03-18	1987-06-02	Taisho Pharmaceutical Co., Ltd.	Method for selective methylation of erythromycin a derivatives
US5141926A (en) *	1990-04-18	1992-08-25	Abbott Laboratories	Erythromycin derivatives
DK0623021T3 (da) *	1992-01-21	1999-02-08	Abbott Lab	4"-deoxyerythromycinderivater

1997
- 1997-12-01 US US08/980,918 patent/US5932710A/en not_active Expired - Lifetime
1998
- 1998-11-17 JP JP2000523223A patent/JP2001525331A/ja active Pending
- 1998-11-17 PT PT98958055T patent/PT1042340E/pt unknown
- 1998-11-17 DE DE69826520T patent/DE69826520T2/de not_active Expired - Fee Related
- 1998-11-17 AU AU14173/99A patent/AU1417399A/en not_active Abandoned
- 1998-11-17 CA CA002309963A patent/CA2309963C/en not_active Expired - Fee Related
- 1998-11-17 DK DK98958055T patent/DK1042340T3/da active
- 1998-11-17 AT AT98958055T patent/ATE277063T1/de not_active IP Right Cessation
- 1998-11-17 IL IL13608898A patent/IL136088A0/xx unknown
- 1998-11-17 ES ES98958055T patent/ES2229550T3/es not_active Expired - Lifetime
- 1998-11-17 WO PCT/US1998/024547 patent/WO1999028332A1/en not_active Ceased
- 1998-11-17 EP EP98958055A patent/EP1042340B1/en not_active Expired - Lifetime
- 1998-11-17 KR KR1020007005970A patent/KR20010032688A/ko not_active Withdrawn
1999
- 1999-04-29 US US09/301,773 patent/US6194387B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP1042340A1 (en)	2000-10-11
US5932710A (en)	1999-08-03
ATE277063T1 (de)	2004-10-15
EP1042340B1 (en)	2004-09-22
CA2309963C (en)	2008-06-17
CA2309963A1 (en)	1999-06-10
JP2001525331A (ja)	2001-12-11
AU1417399A (en)	1999-06-16
IL136088A0 (en)	2001-05-20
WO1999028332A1 (en)	1999-06-10
KR20010032688A (ko)	2001-04-25
PT1042340E (pt)	2004-12-31
DE69826520T2 (de)	2005-12-01
US6194387B1 (en)	2001-02-27
ES2229550T3 (es)	2005-04-16
DE69826520D1 (en)	2004-10-28

Publication	Publication Date	Title
ATE277063T1 (de)	2004-10-15	6-o-alkylerythromycinoxim b
DK0891371T3 (da)	2004-04-13	9-oximsilylerythromycin A derivater
WO1989006649A3 (en)	1989-12-28	Antibacterial agents
SI0680967T1 (en)	1999-02-28	Erythromycin derivatives, their process of preparation and their use as medicaments
NO951198L (no)	1995-10-02	Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene
NL300331I1 (nl)	2008-03-03	Kweken van lawsonia intracellularis, vaccins tegenlawsonia
BG103945A (bg)	2000-07-31	Производни на 4"-заместен-9-деоксо-9а-аза-9а- хомоеритромицин а
AP9801378A0 (en)	2000-04-29	9-amino-3- keto erythromycin derivatives.
AP9801253A0 (en)	1999-12-04	9-Oxime erythromycin derivatives.
NZ337246A (en)	2000-07-28	Pharmaceutical composition comprising amoxycillin and clavulanate
ES8800160A1 (es)	1987-10-16	Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
EE200000587A (et)	2002-04-15	Uued 15-lülilised ketoasaliidid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline kompositsioon kasutamiseks bakternakkuste ravis
ATE71113T1 (de)	1992-01-15	Antibiotikum a 40926 mannosyl aglycon.
TR199900661T2 (xx)	1999-06-21	Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
IS6559A (is)	2002-09-20	Notkun á azalíð sýklalyfssamsetningum til að meðhöndla eða fyrirbyggja bakteríu- eða frumdýrasýkingu í spendýrum
DK312688A (da)	1988-06-09	Glykkopeptid-antibiotika
MD1788G2 (ro)	2002-05-31	Derivaţi de 9-O-oximă ai Eritromicinei A, compoziţie farmaceutică pe baza lor şi metodă de tratament al bolilor infecţioase
TR199900662T2 (xx)	1999-06-21	1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�
LV12172A (lv)	1998-12-20	Kompozicija organu kriokonservesanai um virusu un bakterialas infekcijas arstesanai
AP9801235A0 (en)	1999-11-07	Erythromycin derivatives.
ZA9711101B (en)	1998-12-10	Derivatives of erythromycin their preparation process and their use as medicaments
EG18213A (en)	1992-09-30	Pharmaceutical formulation for the treatment of bacterial infections
FI970933L (fi)	1997-05-05	Entraalinen rokote vaginaalisia infektioita vastaan
NO178302C (no)	1996-02-28	Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte 3-tia- henholdsvis 3-oksa-alkylflavoner, samt mellomprodukter for fremgangsmåten
AU4272596A (en)	1997-03-19	Production process of the ecological pharmaceutical compositions in the veterinary medical field